Publications To Date

    nCOUNTER PUBLICATIONS

    Filter Publications

    PAGE 5 OF 65 | DISPLAYING 61 - 75 OF 973 RESULTS

    Wong WJ et al., Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory signatures., , PLoS One, May 09, 2019

    Siegel BI et al., Host Genome Variation is Associated with Neurocognitive Outcome in Survivors of Pediatric Medulloblastoma, , Transl Oncol., May 09, 2019

    Ghandi M et al. Next-generation characterization of the Cancer Cell Line Encyclopedia., , Nature, May 08, 2019

    Monteiro AC et al., Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma, , Mol Oncol., May 08, 2019

    Waks AG et al., The immune microenvironment in hormone receptor-positive breast cancer before and after preoperative chemotherapy., , Clin Cancer Res. , May 06, 2019

    Vázquez-Arreguín K et al., Oct1/Pou2f1 is selectively required for colon regeneration and regulates colon malignancy, , PLoS Genet., May 06, 2019

    Allen CT et al., Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis, , J Immunother Cancer, May 03, 2019

    Klanova M et al., Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy, , Clin Cancer Res., May 03, 2019

    Stewart RL et al., A multigene assay determines risk of recurrence in patients with triple-negative breast cancer., , Cancer Res, May 02, 2019

    Boldrini L et al., Distinct Angiogenic microRNA-mRNA Expression Profiles Among Subtypes of Lung Adenocarcinoma., , Pathol Oncol Res., May 02, 2019

    Ahmad ST et al., Capicua regulates neural stem cell proliferation and lineage specification through control of Ets factors., , Nat Commun, May 01, 2019

    Perez-Ruiz E et al., Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy, , Nature, May 01, 2019

    Lenz HJ et al., Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance)., , J Clin Oncol., May 01, 2019

    Docking TR et al., Genomic testing in myeloid malignancy, , Int J Lab Hematol., May 01, 2019

    Davies A et al., Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial, , Lancet Oncol., May 01, 2019